Effectiveness of the α-tocopherol, ursodeoxycholic acid, and AZHEPOFIT phyto-complex against the statin model of drug-induced hepatitis

Rena Jafarova, Sevinj Abasova


Background: Drug-induced hepatitis is a common and serious side effect of many medications. Treatment for this condition is often difficult and limited, and there is a need for effective treatment options. The aim of this study was to investigate the effectiveness of α-tocopherol acetate, ursodeoxycholic acid, and AZHEPOFIT phyto-complex against the background of a statin model of drug-induced hepatitis. 

Methods: The study was conducted on 70 white mongrel rats, divided into two groups and treated for 2 weeks twice a day. Statistical analysis was carried out by the Mann-Whitney-Wilcoxon method using MS EXCEL and S-PLUS software.

Results: Against the background of the statin hepatitis model, the combined use of the phyto-complex and ursodeoxycholic acid showed the best results. The atherogenicity index decreased from 16.03 to 2.29, the De Ritis ratio decreased from up to 1.49±0.05, and the severity of lipid peroxidation, the content of c-reactive protein, and medium molecular weight peptides decreased. All of these results indicate the restoration of the functional state of the liver.

Conclusion: The use of α-tocopherol acetate, ursodeoxycholic acid, and AZHEPOFIT phyto-complex can be an effective treatment option for drug-induced hepatitis caused by statin medication. The combination of phyto-complex and ursodeoxycholic acid showed the best results in reducing.

Keywords: Statin drug-induced hepatitis; α-tocopherol acetate; Ursodeoxycholic acid; AZHEPOFIT phyto-complex; Atherogenicity index; De Ritis ratio    

Full Text:



Rao A, Rule JA, Hameed B, Ganger D, Fontana RJ, Lee WM. Secular Trends in Severe Idiosyncratic Drug-Induced Liver Injury in North America: An Update From the Acute Liver Failure Study Group Registry. American Journal of Gastroenterology, (2022);117: 617–626.

RatnikovaI A, Sadanov AK, Gavrilova NN, Orazymbet SE, Kaptagai RZh. Selection of Medicinal Plants Suppressing Growth of Multidrug-Resistant Strain of Tuberculosis Causative Agent. Research Journal of Pharmacy and Technology, (2021); 14(4):2115-8.

Toktogulova N, Breidert M, Sultanalieva R, Tuhvatshin R, Kazieva A. Features of Metabolic Associated Fatty Liver Disease in the Central Asian Population in Low and High Altitudes. GacetaMédica De Caracas, (2022); 130(4): 772-780.

Mengoli M, Parmeggiani D, Mengoli MC, Grinzi G,Tolomelli S. Drug-induced hepatotoxicity: clinical and biochemical features of 26 patients and a review of the literature. RecentiProgressi In Medicina, (2011); 102: 253-260.

Andrade RJ, Aithal GP, Björnsson ES, Kaplowitz N, Kullak-Ublick GA, Larrey D, Karlsen TH. EASL Clinical Practice Guidelines: Drug-induced liver injury. Journal of Hepatology, (2019); 70: 1222–1261.

Isaacson M,Babich M. Drug-Induced Liver Injury Resources and Reporting for the Clinician. Clinicsin Liver Disease, (2020); 24: 131-139.

Ahmad J, Odin JA, Hayashi PH, Fontana RJ, Conjeevaram H, AvulaB, Khan IA,Barnhart H, VuppalanchiR, Navarro VJ.Liver injury associated with kratom, a popular opioid-like product: Experience from the U.S. drug induced liver injury network and a review of the literature. Drug and Alcohol Dependence, (2021); 218.

Singh S, Singh PP, Singh AG, Murad MH, Sanchez W. Statins Are Associated with a Reduced Risk of Hepatocellular Cancer: A Systematic Review and Meta-analysis. Gastroenterology, (2013); 144: 323–332.

Hillman L, Gottfried M, Whitsett M, Rakela J, Schilsky M, Lee WM, Ganger D. Clinical Features and Outcomes of Complementary and Alternative Medicine Induced Acute Liver Failure and Injury. American Journal of Gastroenterology, (2016); 111: 958–965.

PoluchovaSchM, Musaeva EM, Gusejnova GA, Gasymova CV and Dzhavarova RE. Drug-induced hepatopathy. VestnikVitebskogogosudarctvennogomeditsinskogouniversiteta, (2018); 17: 29–36.

ChiuWC, Shan JC, Yang YH, Chen VCH, Chen PC. Statins and the risks of decompensated liver cirrhosis and hepatocellular carcinoma determined in patients with alcohol use disorder. Drug and Alcohol Dependence, (2021); 228.

LaiGY, Weinstein SJ, Taylor PR, McGlynnKA, VirtamoJ, Gail MH, Albanes D, Freedman ND. Effects of a-tocopherol and ß-carotene supplementation on liver cancer incidence and chronic liver disease mortality in the ATBC study. British journal of cancer, (2014); 111(12): 2220–2223.

PacanaT, Sanyal AJ. Vitamin E and nonalcoholic fatty liver disease. Current opinion in clinical nutrition and metabolic care, (2012); 15(6): 641–648.

Wang B, HuL, Chen Y, Zhu B, Kong W, Zhu Z, Wang K, YuQ, Zhang W, Wu G, Sun Y, Xia Zh. Aspartate transaminase/alanine transaminase (De Ritis ratio) predicts survival in major burn patients. Burns, (2022); 48(4): 872–879.

Liu Q, Yan H, Ding X, Li Y, Li X, Xiong Y. Effect of curcumin on liver function of rats with nonalcoholic fatty liver disease. Chinese Journal of Clinical Pharmacology, (2019); 35(1): 80-84.

Won KB, Heo R, Park HB, Lee BK, Lin FY, et al. Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors. Atherosclerosis, (2021); 324: 46–51.

Rashid F, Khan AA.A review of the hepatoprotective effects of medicinal plants used in traditional medicine. Journal of ethnopharmacology, (2018); 208: 67-96.

Xie W, Huang X, Wang Y, Tang Y. Antioxidant activities and hepatoprotective effect of a polysaccharide from Gynostemmapentaphyllum against carbon tetrachloride-induced liver injury in mice. International journal of biological macromolecules, (2019);126: 835-841.

Gendrikson LN, Vinnickaja EV, Homeriki SG, Sbikina ES and Sadler YuG. Drug-induced liver injury induced by vitamin A and E intake. Effective Pharmacotherapy, (2019); 15: 56-62.

Sahni A,Jogdand SD. Effects of Intrahepatic Cholestasis on the Foetus During Pregnancy. Cureus, (2022); 14(10).

Ore A,Akinloye OA. Phytotherapy as Multi-Hit Therapy to Confront the Multiple Pathophysiology in Non-Alcoholic Fatty Liver Disease: A Systematic Review of Experimental Interventions. Medicina (Kaunas, Lithuania), (2021); 57(8).

Nugmanov AB, Mamikhin SV, Valiev KK, Bugubaeva AU, Tokusheva AS,Tulkubaeva SA, BulaevAG. Poly-Species Phytocenoses for Ecosystem Restoration of Degraded Soil Covers. OnLine Journal of Biological Sciences, (2022); 22(3): 268-278.

Sherimova SK, Sarsembayeva NB, Abdigaliyeva TB, Lozowicka B.Vermikom feed additive effects on dairy cows' blood and milk parameters, Veterinary World, (2022); 15(5): 1228-1236.

SysoevPA,VezirkhanovAZ, KafarovES. Variant Anatomy of Blood Supply Sources of Human Kidney Segments. Journal of Morphological Sciences, (2022); 39: 521-528.

Toktogulova N, Tuhvatshin R. Features of the Course of Non-alcoholic Fatty Liver Disease in Experimental Animals at High Altitudes. Open Access Macedonian Journal of Medical Sciences, (2021); 9(A): 1092–1096.


  • There are currently no refbacks.